As for the 5-HT2C receptor, studies indicate the possibility for the treatment of obesity and disorders associated with the consumption of psychostimulant drugs through the activation of this receptor, and for the treatment of anxiety, depression, and schizophrenia using 5-HT2C antagonists. This evidence concerns the gene HTR2C and depressive symptom measurement.